IE
IBIO icon

Israel Englander’s iBio IBIO Stock Holding History

Israel Englander’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.89M Buy
1,651,473
+101,623
+7% +$182K ﹤0.01% 3511
2026
Q1 		$2.94M Buy
+1,549,850
New +$3.6M ﹤0.01% 3484
2023
Q1 		– Sell
-3,535
Closed -$31K – 6578
2022
Q4 		$31K Sell
3,535
-1,323
-27% -$44.8K ﹤0.01% 5924
2022
Q3 		$414K Sell
4,858
-4,373
-47% -$602K ﹤0.01% 5121
2022
Q2 		$1.22M Buy
+9,231
New +$1.39M ﹤0.01% 4199
2022
Q1 		– Sell
-192
Closed -$53K – 7146
2021
Q4 		$53K Buy
+192
New +$73.2K ﹤0.01% 6462
2021
Q3 		– Sell
-38
Closed -$29K – 6989
2021
Q2 		$29K Sell
38
-329
-90% -$240K ﹤0.01% 6415
2021
Q1 		$282K Buy
367
+105
+40% +$91.5K ﹤0.01% 5253
2020
Q4 		$137K Sell
262
-263
-50% -$214K ﹤0.01% 4963
2020
Q3 		$533 Buy
525
+279
+113% +$404K ﹤0.01% 3542
2020
Q2 		$273K Buy
246
+72
+41% +$47.1K ﹤0.01% 3710
2020
Q1 		$92K Buy
+174
New +$67K ﹤0.01% 3564
2016
Q3 		– Sell
-2
Closed -$7K – 3405
2016
Q2 		$7K Sell
2
-9
-82% -$29.4K ﹤0.01% 3120
2016
Q1 		$31K Buy
+11
New +$31.5K ﹤0.01% 3175
2014
Q4 		– Sell
-3
Closed -$9K – 4074
2014
Q3 		$9K Buy
+3
New +$7.32K ﹤0.01% 3639

Other funds holding IBIO

AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Israel Englander's IBIO Position: Q2 2026 in Review

Israel Englander increased its iBio (IBIO) stake by 6.6% in Q2 2026, buying an estimated $182K and bringing the position to 1,651,473 shares worth $2.89M. The position accounts for ﹤0.01% of the portfolio, ranked #3511.

Israel Englander first reported a position in IBIO in Q3 2014 and has held it in 15 quarters since. The position peaked at $2.94M in Q1 2026. 55 funds tracked by Wall St. Rank hold IBIO as of Q2 2026.

  • Israel Englander held 1,651,473 shares of iBio worth $2.89M as of Q2 2026.
  • Israel Englander bought 101,623 iBio shares in Q2 2026, an estimated $182K.
  • iBio made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3511 holding.
  • Israel Englander first reported a position in iBio in Q3 2014 and has held it in 15 quarters since.
  • Israel Englander's iBio position peaked at $2.94M in Q1 2026.
  • 55 funds tracked by Wall St. Rank held iBio as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.